Trial intelligence / Profile preview

Transdermal Estrogen and Bone Mass in Adolescent Anorexia Nervosa

DRKS00014360Phase 2Not yet recruiting

Sponsor
Universitätsklinikum Freiburg
Start
May 2019
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in anorexia nervosa (AN) comparing Transdermal estradiol plus dydrogesterone with Placebo patch plus placebo dydrogesterone (2 arms). Planned start May 2019; status: not yet recruiting.

02

Drugs

estradiol
03

Conditions

anorexia nervosa (AN)

Beyond the preview

Go deeper on DRKS00014360.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00014360.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call